Literature DB >> 6997892

The pathopharmacology of malignant hyperpyrexia.

M A Denborough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6997892     DOI： 10.1016/0163-7258(80)90023-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  4 in total

Review 1.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

2.  Dantrolene inhibits halothane-induced membrane reorganization. A study using 31P-NMR and differential scanning calorimetry.

Authors:  S Gaillard; E J Dufourc; M Bonnet; J P Renou
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

3.  C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.

Authors:  M Steinfath; S Singh; J Scholz; K Becker; C Lenzen; F Wappler; A Köchling; N Roewer; J Schulte am Esch
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599

4.  Propofol for anesthesia in a patient susceptible to malignant hyperthermia.

Authors:  M B Rosenberg
Journal:  Anesth Prog       Date:  1991 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.